Additional NSCLC transcriptional biomarkers (KRT18, CEACAM6, HOPX, FOXC1, CDH1) were also enriched in sorted samples (Supplementary Fig. 11a, b)27–29. This evidence concerns the gene CEACAM6 and non-small cell lung carcinoma.